FitLife Brands (FTLF) Competitors

FitLife Brands (NASDAQ:FTLF) and Immunome (NASDAQ:IMNM) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their earnings, valuation, community ranking, media sentiment, institutional ownership, risk, profitability, analyst recommendations and dividends.

Does the MarketBeat Community favor FTLF or IMNM?

Immunome received 29 more outperform votes than FitLife Brands when rated by MarketBeat users. Likewise, 73.81% of users gave Immunome an outperform vote while only 50.00% of users gave FitLife Brands an outperform vote.

Company	Underperform	Outperform
FitLife Brands	Outperform Votes 2 50.00%	Underperform Votes 2 50.00%
Immunome	Outperform Votes 31 73.81%	Underperform Votes 11 26.19%

Which has more volatility and risk, FTLF or IMNM?

FitLife Brands has a beta of 1.01, suggesting that its stock price is 1% more volatile than the S&P 500. Comparatively, Immunome has a beta of 1.82, suggesting that its stock price is 82% more volatile than the S&P 500.

Is FTLF or IMNM more profitable?

FitLife Brands has a net margin of 13.38% compared to Immunome's net margin of -3,014.59%. FitLife Brands' return on equity of 28.03% beat Immunome's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
FitLife Brands	13.38%	28.03%	15.13%
Immunome	-3,014.59%	-48.63%	-41.62%

Which has better earnings and valuation, FTLF or IMNM?

FitLife Brands has higher revenue and earnings than Immunome. Immunome is trading at a lower price-to-earnings ratio than FitLife Brands, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
FitLife Brands	$52.70M	2.78	$5.30M	$1.69	18.83
Immunome	$10.13M	57.49	-$106.81M	-$8.11	-1.15

Do insiders and institutionals hold more shares of FTLF or IMNM?

2.3% of FitLife Brands shares are held by institutional investors. Comparatively, 44.6% of Immunome shares are held by institutional investors. 61.3% of FitLife Brands shares are held by insiders. Comparatively, 8.6% of Immunome shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Does the media refer more to FTLF or IMNM?

In the previous week, Immunome had 6 more articles in the media than FitLife Brands. MarketBeat recorded 19 mentions for Immunome and 13 mentions for FitLife Brands. Immunome's average media sentiment score of -0.03 beat FitLife Brands' score of -0.17 indicating that Immunome is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
FitLife Brands	2 Very Positive mention(s)	0 Positive mention(s)	6 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral
Immunome	3 Very Positive mention(s)	0 Positive mention(s)	6 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Neutral

Do analysts prefer FTLF or IMNM?

FitLife Brands currently has a consensus price target of $40.00, indicating a potential upside of 25.67%. Immunome has a consensus price target of $28.83, indicating a potential upside of 209.04%. Given Immunome's higher possible upside, analysts plainly believe Immunome is more favorable than FitLife Brands.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
FitLife Brands	0 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	3.50
Immunome	0 Sell rating(s)	0 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	3.00

Summary

FitLife Brands beats Immunome on 10 of the 19 factors compared between the two stocks.